Pharmacopoeias and Herbal Monographs: WHO, EMA and National Standards
What pharmacopoeias and herbal monographs are, how the EU, the UK and WHO use them, and why a quality standard or monograph is not the same as proof that an herb works.
Content last updated . This page has not been medically reviewed.
What these documents are
A pharmacopoeia is an official book of quality standards for medicines and their ingredients. A monograph is a single entry: for an herb, it names the plant material and sets out how to confirm that it is the right plant and meets quality limits. Some monographs also summarize safety and use. Different organizations write different kinds, and the difference matters when a label says "meets monograph standards."This page covers the sources read for this site: the European Medicines Agency (EMA), the British Pharmacopoeia, WHO, and one mention of the Japanese Pharmacopoeia. Other countries have their own pharmacopoeias, which are not described here.
European Union herbal monographs
The EMA's Committee on Herbal Medicinal Products (HMPC) prepares EU herbal monographs. An EU monograph contains the committee's scientific opinion on safety and efficacy data about a herbal substance and its preparations intended for medicinal use. [1] The committee looks at non-clinical and clinical data and also at documented long-standing use. [1]Each monograph has two kinds of entry, and the difference is important for how to read them:
| Section | Basis | What it means |
|---|---|---|
| Well-established use (marketing authorisation) | Sufficient safety and efficacy data | Demonstrated with sufficient safety and efficacy data [1] |
| Traditional use (simplified registration) | Sufficient safety data and plausible efficacy | Long use plus a safety review; not clinical proof of benefit [1] |
For traditional-use registration, the EU requires use for at least 30 years, including at least 15 within the EU. [2] Member States are not obliged to follow the monographs, though a decision not to accept one should be duly justified. [1] A separate EU "list entry" is legally binding on applicants and national authorities. [1]
The HMPC also cooperates with the European Directorate for the Quality of Medicines and Healthcare on European Pharmacopoeia standards. [3] So there are two layers: quality standards (is it the right plant, and is it clean?) and a scientific opinion on use. For the national picture in Europe see traditional herbal medicinal products in the EU.
The British Pharmacopoeia
In the UK, the British Pharmacopoeia Commission must prepare editions of the British Pharmacopoeia at intervals it thinks appropriate. [4] The Commission's 2025 report lists work on herbal monographs, including new extract monographs for green tea dry extract and decaffeinated green tea extract in the 2025 edition. [5] It also records an update to the chapter on DNA-based identification techniques. [5] That kind of testing is about confirming which plant is in a product, which matters because substitution of one botanical for another is a documented hazard. [6]WHO monographs and collection guidelines
WHO published a volume titled WHO monographs on selected medicinal plants. [7] It also published guidelines on good agricultural and collection practices for medicinal plants in 2003, which address how plants are grown and harvested. [8] See WHO reports and guidance for WHO's wider work.Japan
A review of Kampo research says quality control of purity and toxicity is standardized in Japan, following the Japanese Pharmacopoeia and international good manufacturing and laboratory practice rules. [9] Details are on the Kampo formulas page.What a monograph does not do
- It does not make a product safe for everyone. Quality limits address identity and purity. They do not remove interaction, pregnancy or liver risks.
- A traditional-use monograph is not a trial result. The EU says traditional use is accepted on sufficient safety data and plausible efficacy. [1]
- It does not cover every product. In the US, FDA says it is not authorized to approve dietary supplements for safety and effectiveness before they are marketed. [10]
- A passing quality test does not remove contamination risk across the market. NCCIH says some Ayurvedic preparations may contain lead, mercury or arsenic in amounts that can be toxic. [11]
How to use this when shopping or asking questions
Ask which standard a label means: a national pharmacopoeia, an EU registration, or only the maker's own claim. Ask for the plant's Latin name, the part used and the extract. Read reading supplement labels and product quality and contamination. Tell your clinician or pharmacist about herbal products you use, especially with prescription medicines, pregnancy or children. [12]Frequently asked questions
What is the difference between a pharmacopoeia and a monograph?
A pharmacopoeia is an official collection of standards; a monograph is one entry within it for a given substance. The British Pharmacopoeia Commission prepares editions of the British Pharmacopoeia. [4]
What does an EU herbal monograph include?
The HMPC's scientific opinion on safety and efficacy data for a herbal substance and its preparations. [1]
Does a traditional-use monograph mean an herb works?
No. Traditional use is accepted on sufficient safety data and plausible efficacy. [1]
Are EU monographs legally binding?
Member States are not obliged to follow them, but EU list entries are legally binding. [1]
Does a pharmacopoeia standard guarantee a supplement is safe?
No. In the US, FDA does not approve supplements for safety and effectiveness before they are marketed. [10]
References
- European Medicines Agency. European Union monographs and list entries. Read 2026-10-22.
- European Medicines Agency. Herbal medicinal products. Read 2026-10-22.
- European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). Read 2026-10-22.
- UK Government. The Human Medicines Regulations 2012, regulation 317 (Pharmacopoeia and compendia). Read 2026-10-22.
- British Pharmacopoeia Commission. Annual Report 2025 (UK Government). Read 2026-10-22.
- Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney International 2008. PubMed 18418355. Read 2026-10-22.
- World Health Organization. WHO monographs on selected medicinal plants (publication record, copyright 1999). Read 2026-10-22.
- World Health Organization. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants (publication record, 2003). Read 2026-10-22.
- Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine, the state of research and methodological suggestions for the future. Evidence-Based Complementary and Alternative Medicine 2011. Read 2026-10-22.
- US Food and Drug Administration. Information for Consumers on Using Dietary Supplements. Read 2026-10-22.
- National Center for Complementary and Integrative Health (NCCIH, US). Ayurvedic Medicine: In Depth. Read 2026-10-22.
- NCCIH (US). 6 Things To Know When Selecting a Complementary Health Practitioner. Read 2026-10-22.